154 related articles for article (PubMed ID: 16596262)
1. Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease.
Kölsch H; Lütjohann D; Jessen F; Von Bergmann K; Schmitz S; Urbach H; Maier W; Heun R
Int J Mol Med; 2006 May; 17(5):791-4. PubMed ID: 16596262
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer's disease.
Kölsch H; Lütjohann D; Jessen F; Urbach H; von Bergmann K; Maier W; Heun R
J Neural Transm (Vienna); 2006 Feb; 113(2):231-8. PubMed ID: 15959845
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.
Kölsch H; Lütjohann D; Ludwig M; Schulte A; Ptok U; Jessen F; von Bergmann K; Rao ML; Maier W; Heun R
Mol Psychiatry; 2002; 7(8):899-902. PubMed ID: 12232784
[TBL] [Abstract][Full Text] [Related]
4. Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease.
Sundar PD; Feingold E; Minster RL; DeKosky ST; Kamboh MI
Neurobiol Aging; 2007 Jun; 28(6):856-62. PubMed ID: 16725228
[TBL] [Abstract][Full Text] [Related]
5. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease.
Wollmer MA; Streffer JR; Lütjohann D; Tsolaki M; Iakovidou V; Hegi T; Pasch T; Jung HH; Bergmann Kv; Nitsch RM; Hock C; Papassotiropoulos A
Neurobiol Aging; 2003; 24(3):421-6. PubMed ID: 12600718
[TBL] [Abstract][Full Text] [Related]
6. Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients.
Sauder S; Kölsch H; Lütjohann D; Schulz A; von Bergmann K; Maier W; Heun R
J Neural Transm (Vienna); 2005 Oct; 112(10):1381-9. PubMed ID: 15666037
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of cholesterol 24-hydroxylase and ATP-binding cassette transporter A1 polymorphisms with Alzheimer's disease].
Wang F; Jia JP
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(9):614-8. PubMed ID: 17550732
[TBL] [Abstract][Full Text] [Related]
8. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.
Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Buschfort R; Ptok U; Björkhem I; von Bergmann K; Heun R
J Psychiatr Res; 2002; 36(1):27-32. PubMed ID: 11755458
[TBL] [Abstract][Full Text] [Related]
9. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.
Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Schmitz S; Maier W; Heun R
Eur Psychiatry; 2009 Apr; 24(3):183-90. PubMed ID: 19286353
[TBL] [Abstract][Full Text] [Related]
10. Differences in ABCA1 R219K Polymorphisms and Serum Indexes in Alzheimer and Parkinson Diseases in Northern China.
Ya L; Lu Z
Med Sci Monit; 2017 Sep; 23():4591-4600. PubMed ID: 28943632
[TBL] [Abstract][Full Text] [Related]
11. Epistasis between intracellular cholesterol trafficking-related genes (NPC1 and ABCA1) and Alzheimer's disease risk.
Rodríguez-Rodríguez E; Vázquez-Higuera JL; Sánchez-Juan P; Mateo I; Pozueta A; Martínez-García A; Frank A; Valdivieso F; Berciano J; Bullido MJ; Combarros O
J Alzheimers Dis; 2010; 21(2):619-25. PubMed ID: 20571217
[TBL] [Abstract][Full Text] [Related]
12. Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk.
Rodríguez-Rodríguez E; Mateo I; Infante J; Llorca J; García-Gorostiaga I; Vázquez-Higuera JL; Sánchez-Juan P; Berciano J; Combarros O
Brain Res; 2009 Jul; 1280():166-71. PubMed ID: 19446537
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls.
Schönknecht P; Lütjohann D; Pantel J; Bardenheuer H; Hartmann T; von Bergmann K; Beyreuther K; Schröder J
Neurosci Lett; 2002 May; 324(1):83-5. PubMed ID: 11983301
[TBL] [Abstract][Full Text] [Related]
14. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.
Vega GL; Weiner M; Kölsch H; von Bergmann K; Heun R; Lutjohan D; Nguyen A; Moore C
Curr Alzheimer Res; 2004 Feb; 1(1):71-7. PubMed ID: 15975088
[TBL] [Abstract][Full Text] [Related]
15. CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk.
Qureischie H; Heun R; Lütjohann D; Popp J; Jessen F; Ledschbor-Frahnert C; Thiele H; Maier W; Hentschel F; Kelemen P; Kölsch H
Brain Res; 2008 Sep; 1232():1-6. PubMed ID: 18680734
[TBL] [Abstract][Full Text] [Related]
16. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
Lütjohann D; von Bergmann K
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
[TBL] [Abstract][Full Text] [Related]
17. Genotypic variation in ATP-binding cassette transporter-1 (ABCA1) as contributors to the high and low high-density lipoprotein-cholesterol (HDL-C) phenotype.
Mantaring M; Rhyne J; Ho Hong S; Miller M
Transl Res; 2007 Apr; 149(4):205-10. PubMed ID: 17383594
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese.
Wang F; Jia J
Brain Res; 2007 May; 1147():34-8. PubMed ID: 17335784
[TBL] [Abstract][Full Text] [Related]
19. Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.
Xiao Z; Wang J; Chen W; Wang P; Zeng H; Chen W
Lipids Health Dis; 2012 Nov; 11():163. PubMed ID: 23181436
[TBL] [Abstract][Full Text] [Related]
20. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.
Lütjohann D; Papassotiropoulos A; Björkhem I; Locatelli S; Bagli M; Oehring RD; Schlegel U; Jessen F; Rao ML; von Bergmann K; Heun R
J Lipid Res; 2000 Feb; 41(2):195-8. PubMed ID: 10681402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
